VEGF was delivered to the lower limb skeletal muscle of patients with peripheral artery disease using a therapeutic-mediated cytokine delivery strategy, and VEGF was shown to modulate endothelial function and lower limb flow reserve in patients with peripheral artery disease [18]. The gene discussed is VEGFA; the disease is peripheral arterial disease.